SciSight Ecosystem
WoS SCIE Q1Scopus Q1SCImago #264CAS 1区Top JournalReview JournalHybrid

Drug Resistance Updates

Abbreviation (ISO):DRUG RESIST UPDATE
Country: England•WoS SCIE Quartile: Q1•Scopus SJR: 5.279•SCImago Rank: #264•Identifier (ISSN):1368-7646(Print)/1532-2084(Online)•Articles / Year: 21•Estimated Publication Fee (APC): $4,427 USD
Clarivate IF (2026)Q1
22
↑ +0.3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17
H-Index (2021)
100

100 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate4.4%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
21articles/year
35.71% Gold OA•6.25% Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

3.00pts
Latest Max Score
Estimated (Dec 26)
Scoring Basis: WoS Q1 có IF ≥ 5.0(IF: 22)

HĐGSNN Score History

By article publication year
YearMax ScoreEvaluation DetailsSource
20263.00đ
WoS Q1 có IF ≥ 5.0(IF: 22)
🔵 Computed
20253.00đ
WoS Q1 có IF ≥ 5.0(IF: 21.7)
🔵 Computed
20243.00đ
WoS Q1 có IF ≥ 5.0(IF: 15.8)
🔵 Computed
20233.00đ
WoS Q1 có IF ≥ 5.0(IF: 24.3)
🔵 Computed
20223.00đ
WoS Q1 có IF ≥ 5.0(IF: 22.841)
🔵 Computed
20213.00đ
WoS Q1 có IF ≥ 5.0(IF: 18.5)
🔵 Computed
20203.00đ
WoS Q1 có IF ≥ 5.0(IF: 11)
🔵 Computed
20193.00đ
WoS Q1 có IF ≥ 5.0(IF: 11.708)
🔵 Computed
20183.00đ
WoS Q1 có IF ≥ 5.0(IF: 11.63)
🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine. Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective. *Expert reviews in clinical and basic drug resistance research in oncology and infectious disease *Describes emerging technologies and therapies, particularly those that overcome drug resistance *Emphasises common themes in microbial and cancer research

Topics Covered (Recognized by AI)
Medicine83.1%Biology81%Genetics77.9%Chemistry63.7%Biochemistry62.1%Internal medicine55.7%Microbiology42.1%Cancer39.4%Gene36.5%Cancer research35.6%Pharmacology33%Drug resistance31.8%Immunology28.5%Cell biology25.2%Pathology23.8%Psychology22.5%Psychiatry20.8%Organic chemistry20.5%
Primary Research Areas

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #264Scopus Q1SCImago Profile
Scopus Coverage:1998-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
5.279

Weighted prestige citation metric per document indexed in the Scopus database.

Tứ phân vị: Scopus Q1
Scopus H-Index (2025)
148

Measures cumulative publication volume and citation impact.

Scopus Database Indexed (2025)
Citations / Doc (2 years)
21.95

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$4,427 USD

Estimated Article Processing Charge for Open Access publication.

Chi phí ước tính / bài báo

Scopus 3-Year Publication & Citation Window

3-Year Citations4,287
3-Year Documents201
Citable Documents192

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate39.6%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cancer ResearchQ1
Infectious DiseasesQ1
OncologyQ1
PharmacologyQ1
Pharmacology (medical)Q1

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
1区 (Zone 1)Medicine
Minor Category (Specific Field):
1区PHARMACOLOGY & PHARMACY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Publisher Review Speed
Updating
Average time to first editorial decision
Online Publication Speed
Updating
Time from acceptance to online publication
Official Acceptance Rate
Updating
Manuscript acceptance rate confirmed by the publisher
Open Access Model
Hybrid
OA publishing option or traditional subscription
Publisher
Churchill Livingstone
Publication Language
English
Frequency
Bimonthly
Founding Year
1998
Editorial Address
CHURCHILL LIVINGSTONE, JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, SCOTLAND, MIDLOTHIAN, EH1 3AF
Indexing & Databases
SCIEScopusPubMed

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
CategoryIndexRankQuartile
PHARMACOLOGY & PHARMACY
JCRSCIE
3/356Q1
PHARMACOLOGY & PHARMACY
JCISCIE
2/356Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
YearImpact FactorArticles / YearTotal Citations
2026—100141
202521.71101,344
202415.81153,721
202324.3835,176
202222.841483,447
202118.5273,200
202011283,467
201911.708313,796
201811.63233,037
2017—212,286
2016—355,466
2015—274,567
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Impact Factor Trend (2018–2024)

Clarivate IF trend for Drug Resistance Updates

WoS Q1
71421282018201920202021202220232024202521.70
Annual Impact Factor Metric
2025:21.7

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.4%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 6e17e2e0-e90c-4294-bb5d-0ab3c75eacf7
Database Updated: 2026-10-01